Scheme for Development of Pharmaceuticals Industry
Link to the Programme
It is the major scheme for supporting the pharmaceutical industry in India. It has a total outlay of ₹480 Cr. It functions through its subschemes:
- Assistance to Bulk Drug Industry for Common Facility Centre (₹200 Cr allotted under this subscheme)
- Assistance to Medical Device Industry for Common Facility Centre (₹100 Cr allotted under this subscheme)
- Pharmaceuticals Technology Upgradation Assistance Scheme (PTUAS; ₹144 Cr allotted under this subscheme)
- Assistance for Cluster Development (₹30 Cr allotted under this subscheme)
Pharmaceutical Promotion Development Scheme (PPDS; ₹6 Cr allotted under this subscheme).
Creation of Chemical Hubs, Laboratories and Venture Capital Fund
The department is promoting the creation of chemical hubs, mini drug-testing laboratories, and venture capital fund (worth ₹1,000 Cr to support start-ups) under PPP mode with 50% of public funding matched by 50% private sector funding.
Research Collaborations
- Sanofi India collaborated with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata for promoting academic excellence and research
- Sun Pharma has signed a pact with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel botanical drug for the treatment of dengue
- C 11 member companies ink parts for industry academies cooperation IN 2015
- Linkage agreements of NIPERs with industries such as Sun Pharma, Medley Pharma, Dr Reddy’s Lab, NATCO Cadila Pharma, Cadila Healthcare, Sahjanand Tech, Johnson & Johnson India.